| Model 1 | Model 2 | Model 3 | Model 4 |
---|
Std β | P | Std β | P | Std β | P | Std β | P |
---|
Men |
 Lumbar spine BMD | −0.102 | 0.005 | −0.120 | 0.001 | −0.120 | 0.001 | −0.142 | <0.001 |
 Hip BMD | −0.075 | 0.041 | −0.062 | 0.105 | −0.056 | 0.151 | −0.073 | 0.046 |
 Whole-body BMD | −0.164 | <0.001 | −0.152 | <0.001 | −0.118 | 0.001 | −0.143 | <0.001 |
 25(OH)D | 0.012 | 0.747 | 0.017 | 0.647 | −0.018 | 0.638 | – | – |
 Osteocalcin | −0.093 | 0.012 | −0.085 | 0.019 | −0.102 | 0.006 | – | – |
 β-CTX | 0.001 | 0.994 | 0.001 | 0.981 | 0.002 | 0.952 | – | – |
- Model 1 included liver fat content, age and body weight
- Model 2 included liver fat content, age, body weight, alcohol drinking, cigarrete smoking, anti-osteporotic drug use, SBP, FBG, triglyceride, cholesterol, and uric acid
- Model 3 included liver fat content, age, body weight, alcohol drinking, cigarrete smoking, SBP, FBG, triglyceride, cholesterol, HDL-c,uric acid, body fat percentage, and trunk to appendicular fat ratio
- Model 4 included same as model 3 plus serum 25(OH)D, osteocalcin, andβ-CTx levels
-
Std β denotes standardized β coefficient, BMD bone mineral density, 25(OH)VitD 25-hydroxyvitamin D, β-CTx β-isomerized form carboxy-terminal telopeptide of type I collagen, SBP systolic blood pressure, FBG fasting blood glucose, HDL-c high-density lipoprotein-cholesterol